Updated Announcement - AAPS and FDA Agreement to Build Quantitative Alzheimer’s Disease Model

Abstract

American Association of Pharmaceutical Scientists (AAPS) and Pharmacometrics, Office of Clinical Pharmacology, Food and Drug Administration (FDA) have a Cooperative Research and Development Agreement (CRADA) to build a quantitative Alzheimer’s Disease Model. AAPS is seeking fellows who are interested in applying quantitative ‘learning’ approaches for solving drug development and regulatory challenges. Specifically, the incumbent will work with the FDA Pharmacometrics group (Silver Spring, MD) to develop and apply Alzheimer’s Disease Model to drug development. The fellowship is for 2 years.